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Background: Stroke is a rare but potentially catastrophic complication of cardiac catheterization. While some procedural aspects are known to influence stroke risk, the impact of radial versus femoral access site use is unclear. Early observational studies and limited randomized trial data suggested more frequent embolic events with radial access. Subsequently, larger pooled analyses have shown no clear differences in stroke risk but were limited by low event rates. Recent publication of relevant new data prompted our re-evaluation of this concern.  Therefore, we conducted a systematic review and meta-analysis to evaluate stroke complicating cardiac catheterization with use of  transradial versus transfemoral access. 
Methods and Results: A search of MEDLINE and EMBASE was undertaken using OVID SP with appropriate search terms. RevMan 5.3.5 was used to conduct a random effects meta-analysis using the inverse variance method for pooling risk ratios (RR) or the Mantel-Haenszel method for pooling dichotomous data. Pooled data from over 24,000 patients in randomized controlled trials (RCTs) and over 475,000 patients from observational studies were used. The risk ratio for (any) stroke, using RCT data, was not significant (RR 0.87, 95% CI 0.58-1.29). Using observational data, a significant difference favoring radial access was seen (RR 0.71; 95% CI 0.52-0.98). 





While stroke is a rare complication of percutaneous coronary procedures, it ranks among the most feared, due to the potentially catastrophic consequences. Contemporary series indicate that stroke complicating percutaneous coronary intervention (PCI) increases 30-day mortality by between 4- and 10- fold.1 In those who survive, there is a high incidence of chronic morbidity and loss of independent living.2 
The mechanism of stroke in the setting of cardiac catheterization appears to relate principally to arterial embolism. Studies employing transcranial Doppler demonstrate intermittent cerebral emboli during such procedures.3,4 The etiology of these emboli may be gaseous (from microbubbles, particularly during catheter flushing) or particulate.5 The latter are of greater concern, tend to occur particularly during catheter exchanges, and may potentially represent thrombus, atheromatous material or calcium.5 The risk of PCI-related ischemic stroke/transient ischemic attack (TIA) has been associated with various modifiable procedure-related factors, including the number of catheter exchanges and the caliber of PCI guide catheter, in a retrospective observational study.6 





	This analysis included only studies that i) compared use of radial and femoral access for cardiac catheterization (with or without PCI), and ii) evaluated stroke or examined other markers of subclinical neurological events, namely the demonstration of new lesions on brain magnetic resonance imaging or the detection of microemboli on transcranial Doppler testing. Pooled analysis was performed only for studies reporting stroke. To be eligible, studies also had to report quantitative event data so that assessment of outcomes could be compared between radial and femoral access.  There was no restriction based on study design, cohort type or language of study report.  Studies that did not have any stroke events were excluded because these were underpowered to detect differences in events between radial and femoral access groups.

Search strategy
	A search of MEDLINE and EMBASE was undertaken in September 2015 using OVID SP with no date or language restriction.  The exact search terms were: (transradial or transfemoral or radial artery or femoral artery or radial access or femoral access) AND (angiography or angiogram or catheterization or catheterization or PCI or percutaneous coronary intervention) AND (stroke or microemboli or cerebral infarction or dementia or cognitive impairment).  The bibliographies of relevant original studies and reviews were also checked for additional studies that met our inclusion criteria.

Study selection and data extraction
	Two reviewers (CSK, RK) screened all titles and abstracts retrieved from the search for studies that met the inclusion criteria.  The full manuscript of studies that potentially met all inclusion criteria were reviewed and the final decision to include or exclude studies were made with two other reviewers (AS, MAM).  Independent double extraction was performed from source publications by two reviewers (CSK, RK). Data was collected on study design, year, country, number of participants, mean age, % male, participant inclusion criteria, outcomes evaluated, timing of assessment and results. 

Risk of bias assessment
Quality assessment of studies was conducted with consideration of whether the study was prospective cohort or randomized controlled trial in design, whether both radial and femoral treatment arms had more than 100 participants, whether there were reliable methods for outcome ascertainment, whether loss to follow-up was greater than 10%, and whether there were more than 3 variables with significant baseline differences for randomized trials or use of adjustments or propensity score matching in cohort studies.  Publication bias was evaluated using asymmetry testing if there were more than 10 studies in the meta-analysis, and if there was statistical heterogeneity <50%.12

Data analysis
	RevMan 5.3.5 (Nordic Cochrane Centre) was used to conduct a random effects meta-analysis using the inverse variance method for pooling risk ratios (RR) or the Mantel-Haenszel method for pooling dichotomous data.  Where possible, adjusted risk estimates from primary studies were pooled. Where this data were not available, raw data were used to calculate unadjusted risk estimates. The primary outcome measure was (all) stroke but analysis of ischemic and hemorrhagic stroke types was also performed. The analysis was stratified by whether individual studies were higher quality randomized trials or cohort observational studies.  Statistical heterogeneity was assessed by determining the I2 statistic where I2 values of 30-60% represent a moderate level of heterogeneity.13 We performed additional analysis considering the effect of year of publication on stroke rates and sensitivity analysis by stratifying according to diagnostic procedures, PCI procedures or both diagnostic and PCI procedures.

Results 
Study selection and description
	Figure 1 provides a flowchart of study selection.  Our search results yielded 979 studies, of which 36 met inclusion criteria.1,3,5,7-9,14-45  The reasons for exclusion are shown in Figure 1.  Three studies from the most recent meta-analysis were not included because they had no stroke events.46-48 

	The study design, participant characteristics and clinical settings are shown in Table 1.  The 36 studies comprised 15 randomized controlled trials, 8 prospective cohort studies, 10 retrospective cohort studies and 3 cohort studies of unclear design. The studies were reported between 1997 and 2015. There were a total of 1,112,343 participants who underwent 438,238 radial procedures and 643,469 femoral procedures (the crude number of participant for each access site was not reported for 30,636 participants). The mean age was 65 years across 29 studies that reported age and 70% of participants were male from 31 studies that reported gender.

Quality assessment of included studies
	The quality assessment of included studies is shown in Table 2. Of the 36 included studies, 23 (64%) were RCTs or prospective cohort studies. There were more than 100 participants in both radial and femoral arms of the studies in 25 (69%) studies and reliable methods for ascertaining outcomes were also present in 25 (69%) of studies. Low loss-to-follow up was likely or reported in half the studies (n=24) and there were 3 or fewer variables with significant baseline differences in RCTs, or use of adjustment for confounding in cohort studies, in 16 (44%) studies.

Comparison of stroke and neurological outcomes by access site
	The study outcomes and results are shown in Table 3.  The rate of stroke events from 28 studies (one study did not report crude events) was 0.14% (358 events/249,073 total) in the radial group and 0.19% (472 events/251,095 total) in the femoral group.  The rates of stroke according to publication year are shown in Supplementary Figure 1.  The pooled results showed no significant difference in stroke from RCTs (RR 0.87 95%CI 0.58-1.29, I2=0%) but a significant difference in cohort studies in favor of radial access (RR 0.71 95%CI 0.52-0.98, I2=26%) (Figure 2).
	The risk of ischemic stroke from RCTs and cohort studies is shown in Figure 3.  The rates of ischemic stroke among 5 studies were 0.16% (92 events/57,548 total) and 0.26% (95 events/36,675 total) for the radial and femoral access groups, respectively. The pooled results showed no difference in ischemic stroke from RCTs  (RR 0.92 95%CI 0.41-2.08, I2=57%) but a significant difference in cohort studies again favoring radial access (RR 0.58 95%CI 0.41-0.82, I2=0%).
	The risk of hemorrhagic stroke among RCTs and cohort studies is shown in Figure 4.  The rates of hemorrhagic stroke among 6 studies were 0.026% (15 events/58,050 total) and 0.032% (12 events/37,136 total) for the radial and femoral access groups, respectively. The pooled results indicate no significant difference in hemorrhagic stroke rates between radial and femoral access, from both RCT (RR 0.65 95%CI 0.19-2.15, I2=0%) and cohort studies (RR 0.93 95%CI 0.22-3.93, I2=24%).
	We also performed sensitivity analysis considering whether the procedures were diagnostic, PCI or both.  Our findings are similar to those reported in the main analysis, withof the results suggested  no statistical significance any differenceobserved between radial and femoral access for stroke events by procedure type (Supplementary Figure 2).
Assessment of publication bias
There were more than 10 studies and low levels of heterogeneity in the analysis of any stroke so we constructed a funnel plot to assess publication bias (Figure 5).  There appears to be some evidence of reporting bias.

Additional studies not included in meta-analysis
	Results from a few of the 34 studies that met our inclusion criteria were not pooled as they reported outcomes measures that did not include stroke events alone.  Lund et al studied 42 patients and found 5 cases of new cerebral lesions on diffusion-weighted magnetic resonance imaging (DWI) in the radial but not femoral access group.3  Jurga et al found a higher number of microemboli on transcranial Doppler in the radial compared to the femoral group (10.9±6.3 vs 6.9±4.7, respectively) .5




Stroke remains a feared, although fortunately rare, complication of invasive cardiac procedures due to high mortality and significant chronic morbidity and loss of independent living in survivors. The aggregated events in our analysis indicate an overall stroke rate of only 0.52%, based on data from 13 RCTs, which is comparable to that found in a preceding meta-analysis (0.43%).11 Nevertheless, given the repercussions of stroke on quality of life and functional status, attempts to better understand risks for peri-procedural stroke are certainly warranted. Additionally, whilst overt stroke is rare, the same fundamental processes are likely to underlie development of new white matter lesions on brain MRI after cardiac catheterization, which can occur in the absence of clinical stroke. Such findings are much more frequent than overt stroke in studies that systematically search for them.49,50 These lesions are known to persist at follow-up months later and hence seem to represent permanent injury.51 Such initially ‘silent’ infarcts have been associated with steeper rates of cognitive decline and increased risks for dementia.52 Previous studies from North America that have studied temporal trends in stroke complications following PCI have shown that stroke rates remained fairly constant between 1998-2008, although survival rates have improved over time. In contrast, an analysis for the British Cardiovascular Interventional Society has shown increases in national ischemic stroke rates between 2007-2012 due to changes in PCI activity from elective to ACS indications and higher risk clinical patient demographics, although haemorrhagic stroke complications decreased significantly due to decreased utilisation of GP IIb/IIIa use. Our current analysis suggests that stroke rates have trended downwards both for radial and femoral procedures in both randomised controlled trials and registry studies, although it is not clear what has driven these changes, although may relate to advances in pharmacotherapy and procedural techniques. Nevertheless whilst stroke remains a rare complication of PCI, its outcomes are potentially devastating .
Of particular importance for preventing stroke are potentially modifiable technical aspects of the cardiac catheterization procedure. There are various theoretical mechanisms by which access site choice might alter the risk of cerebral emboli. For example, radial (or brachial) access (particularly from the right upper limb) involves less catheter contact with the aortic arch, a known rich source of potential athero-emboli.53 However, upper limb access routes pass adjacent to the ostia of either the innominate or vertebral arteries, and tortuosity in this region (as frequently encountered in older patients) might predispose to inadvertent guide wire passage into these ostia, or to mechanical pressure from the angulated catheter on atheromatous plaque in the more proximal subclavian artery. Other factors, such as procedure duration, number of catheter exchanges and use of anticoagulation, also impact on risks of embolism and may differ between radial and femoral approaches. Hence the net effect of radial versus femoral access use on neurological events is difficult to predict a priori. Meta-analyses of RCTs to date have not shown any significant difference between access site choices in terms of stroke risk but they have been hampered in the strength of these conclusions by the rarity of events. 


Interpretation of findings from the present study
We used information from over 24,000 patients in RCTs and over 475,000 patients from higher quality observational studies. This provided statistical power to search for differences in a rarely occurring endpoint (stroke). For our principal outcome measure (all stroke), pooled RCT data yielded a non-significant risk ratio of 0.87 (95% CI 0.58-1.29. When looking at (all) stroke in the pooled cohort studies (which are dominated by 2 large series), a significant result favoring radial use emerged, in contrast to the RCT data.  Although these observational studies have greater power in terms of far higher subject numbers, they are of course subject to the usual issues of selection bias, and the particular issue of confounding, that may not be fully corrected by measures such as propensity adjustment. It is therefore possible that the more favorable stroke outcomes with radial use in the observational studies might reflect a lower risk cohort. We have also undertaken sensitivity analyses that study outcomes for diagnostic cardiac catheterisation and PCI separately, and these sensitivity analyses show concordance with the findings of our main analyses, that there are no significant differences in stroke risk associated between cases undertaken through the radial and femoral approach, even in elective diagnostic cases which are undertaken in the absence of anti-coagulation with heparin or bivalirudin. 

Given other highly compelling reasons for choosing radial access (discussed earlier), these aggregate all-stroke data are reassuring and should encourage the continuing increase in radial use now being seen in the United States and elsewhere. 
For the specific endpoint of ischemic stroke, a lower frequency of reporting for this outcome measure led to lower subject numbers for meta-analysis. For the RCTs, this unsurprisingly resulted in a non-significant difference between access sites and wide confidence intervals, limiting the strength of any conclusions. For the cohort data, the findings are driven by the results favoring radial use from a single large series. For hemorrhagic stroke, the issue of low patient numbers and events, with consequent low statistical power, was even more evident. 
Limitations
This study is subject to certain limitations common to all meta-analyses, in terms of susceptibility to reporting and publication bias. Although providing power to comment usefully on all-stroke events, there was insufficient reporting (and hence inadequate patient numbers) to draw any firm conclusions regarding possible subgroups of particular interest – including, for example, comparing those with right versus left radial access (in whom contact with the aortic arch by the catheter is known to differ). Available data on subclinical lesions (new white matter cerebral changes on MRI), with radial versus femoral access, are scant and hence (despite their potential long-term relevance) could not be pooled in the meta-analysis. Finally, whilst our analysis has not shown any statistically significant differences in neurological events between radial and femoral access site use in 24,000 patients derived from RCTs and close to 1/2 million patients in cohort studies, this does not prove equivalence as neurological events are rare complications in PCI and given that the absolute differences in neurological events between the two access sites are small (0.14% and 0.19%), our analysis may still be underpowered to detect small but statistically significant differences.
Conclusions 
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Table 1: Study design, participants and clinical setting
Study ID	Design; Country, Year	No. of participants;  radial; femoral.	Age	% Male	Clinical setting
Achenbach 200814	RCT; Germany; Unclear.	307; 152; 155.	78	45	Participants had in-patient invasive angiography of age at least 75 years.
Benit 199715	RCT; Belgium; 1994-1995.	105; 50; 55.	58	56	Elective angioplasty with the Palmaz-Schatz stent.
Bernat 201416	RCT; International; 2009 to 2012.	707; 348; 359.	62.1	77	Participants had STEMI in STEMI-RADIAL trial.
Brueck 200917	RCT; Germany; 2006-2008.	1,024; 512; 512.	63.6	58.7	Patients with diagnostic or interventional cardiac catheterization
Chodor 200918 	RCT; Poland; 2005-2006.	100; 50; 50.	59.5	68	Participants had STEMI in RADIAMI trial.
Chodor 201119 	RCT; Poland; 2006-2008. 	108; 49; 59.	59.6	64	Participants had STEMI in RADIAMI II trial.
Cooper 199920 	RCT; USA; 1996-1997.	200; 101; 99.	60	69	Participants underwent diagnostic cardiac catheterization.
Cruden 200721	Retrospective cohort study; UK; 2003-2005.	287; 44; 243.	59	82.9	STEMI patients undergoing rescue PCI.
Dangoisse 201322	Prospective cohort study; France; 2002-2007.	3,600; 1,672; 1,928.	65	76	Participants had primary PCI.
De Andrade 201423	Prospective cohort study; Brazil; 2010 -2011.	588; 178; 410.	61.8	75.2	Participants had STEMI in ACCEPT registry.
Deftereos 201024	Retrospective cohort study; Greece; 2009-2010.	98; 65; 33.	64	74.4	Participants had STEMI and underwent primary PCI.
Eyupkoca 201225	Cohort study; Turkey; 2010-2012.	450; 264; 186.	NA	NA	Participants were elderly undergoing coronary angiography.
Genereux 201126	RCT; International; 2005-2007.	3,334; 200; 3,134.	60	77	Participants had STEMI in HORIZON-AMI trial.
Hamon 20129	RCT; France; Unclear.	160; 83; 77.	74.5	54.3	Participants had cardiac catheterization and had aortic stenosis.
Hamon 201527	RCT; International; Unclear.	2,152; 1,012; 1,140.	Median 60 and 63.	69	Participants had STEMI in EUROMAX trial.
He 201528	Retrospective cohort study; China; 2006-2011.	2,728; 1,364; 1,364.	59	68	Participants had PCI.
Jaffe 200729	Prospective cohort study; Canada; 2000-2004, 	228: 97; 131	82.5	59.2	Octogenarians undergoing elective PCI.
Jen 201130	Retrospective cohort study; China; 2005-2007.	117: 85; 37.	66	76.9	Patients with STEMI undergoing  primary PCI.
Jin 201031	Retrospective cohort study; China; 2010.	5,539; 4,888; 651.	NA	NA	Participants had PCI.
Johnman 201232	Retrospective cohort study; Scotland; 2000-2009.	4,534; 2,392; 2,142.	NA	75	Participants had primary or rescue PCI in the Scottish Coronary Revascularisation Register.
Jolly 20117 & Mehta 201233	RCT; International; 2006-2010.	7,021; 3507; 3,514.	62	73	Participants had ACS in RIVAL trial.
Jurga 20115	RCT; Sweden; 2007-2008.	43; 20; 23.	64	86	Participants had coronary angiography.
Jurga 201434	Cohort study; Sweden; 2003 to 2010.	259,045;77,155; 151,086.	66	66	Participants had coronary angiography or PCI in the SCAAR registry.
Kwok 20151	Retrospective cohort study; UK; 2007-2012.	403,646; 177,458; 226,188.	65	73	Participants had PCI in the BCIS dataset.
Louvard 200435	RCT; International; 2001-2003.	377; 192; 185.	83	53	Participants had coronary angiography or PCI and were octogenarians in OCTOPLUS study.
Lund 20053	Prospective cohort study; Norway; Unclear.	42; 33; 9.	59.3	78.7	Participants underwent elective left heart catheterization.
Pristipino 200936	Prospective cohort study; Italy; 2006. 	1052; 509;543	66	71	Participants in the PREVAIL study of primary PCI.
Rapsoso 201537 & Madiera 201338	Prospective cohort study; Portugal; 2006- 2012	16,710; 4,231; 12,479.	66	66.6	Participants underwent diagnostic or interventional cardiac catheterization.
Rodriguez-Leor 201239	Prospective cohort study; Spain; 2007-2012.	122; 80; 42.	66	83.6	Participants had cardiogenic shock and were undergoing PCI.
Romagnoli 201240	RCT; International; 2009-2011	1001; 500; 501.	65	73.3	Participants had early revascularization due to STEACS, participants of the RIFLE STEACS trial.
Romagnoli 201341	Retrospective cohort study; Italy; 2007-2011.	321; 112; 209.	70	72.9	Participants had intraaortic balloon pump and were undergoing PCI.
Sabbah 201342	Retrospective cohort study; Japan; 2006-2012.	3,851; 2,797; 1,054.	NA	NA	Participants underwent PCI.
Sarno 201243	Cohort study; Sweden; 2003-2010.	299,786; 101,060;  198,726.	NA	NA	Participants underwent coronary angiography or PCI in the Swedish coronary angiography and angioplasty registry (SCAAR).
Sciahbasi 200944	Prospective cohort study; Italy; 2006 to 2007.	1,492; 604; 888.	67	67	Participants underwent PCI with radial access or femoral puncture with closure device.
Tizon Marcos 200945	Retrospective cohort study; Canada; 1990-2007.	83,409; 52,191; 31,218.	NA	NA	Participants underwent coronary angiography or PCI.





Table 2: Study quality assessment
Study ID	RCT or prospective design.	Sample size ≥100 participants in each arm.	Reliable ascertainment of outcomes.	Low lost to follow up.	No more than 3 baseline differences between groups (RCT) or use of adjustments (cohorts).
Achenbach 200814	RCT	Yes	Yes, after intervention patients were contacted again by clinical visit or telephone interview.	Yes, no loss to follow up.	Yes, RCT, difference in time to cine angiographic acquisition and duration of diagnostic angiography.
Benit 199715	RCT	No	Yes, follow up in outpatient clinic at 1 month.	Unclear.	Yes, RCT, difference in maximal pressure exerted by balloon and arterial time of the procedure.
Bernat 201416	RCT	Yes	Yes, clinical follow up for 30 days, and telephone follow-up for 6 months.	Yes, no loss to follow up.	Yes, RCT, difference in hypertension and BMI only.
Brueck 200917	RCT	Yes	Unclear methods but prospective collection.	Yes, no loss to follow up.	Yes, RCT, difference in access failure, median procedural time and median fluoroscopy time.
Chodor 200918	RCT	No	Unclear methods but prospective collection.	Yes, no loss to follow up.	Yes, RCT, no difference in baseline characteristics.
Chodor 201119	RCT	No	Unclear methods but prospective collection.	Yes, no loss to follow up.	Yes, RCT, difference in age.
Cooper 199920	RCT	No	Yes, 1 day and 1 week physical examination was performed.	Yes, no loss to follow up.	No, RCT, difference in male sex, aortic valve disease, hypertension and smoking. 
Cruden 200721	Retrospective 	No	Yes, data from interventional database, hospital records and catheter laboratory records.	Unclear.	No, cohort, unadjusted results.
Dangoisse 201322	Prospective	Yes	Yes, procedural, clinical and laboratory data entered into PCI database using hospital's electronic medical record.	Unclear.	No, cohort, unadjusted results.
De Andrade 201423	Prospective	Yes	Yes, data from electronic system.	Yes, 52 cases 8.1% loss to follow up. 	No, cohort, unadjusted results.
Deftereos 201024	Retrospective	Yes	No, retrospective review of clinical and angiographic data.	Yes, no loss to follow up.	No, cohort, unadjusted results.
Eyupkoca 201225	Unclear	Yes	Unclear	Unclear.	No, cohort, unadjusted results.
Genereux 201126	RCT	Yes	Yes, clinical events were adjudicated by blinded events committee.	Unclear.	No, RCT, difference in history of hyperlipidemia, aspirin, thienopyridine, Ca2+ channel blocker, Abciximab, Eptifibatide, given with Bivalirudin for bail out, and ACEi or ARB on discharge.
Hamon 20129	RCT	No	Yes, MRI scan within 24 hours before and 48 hours after and some patients had transcranial Doppler.	Yes, 5 patients refused 2nd MRI or MRI no interpretable.	Yes, RCT, difference in catheters used >3 and anticoagulation per catheter.
Hamon 201527	RCT	Yes	Yes, events were adjudicated by independent, blinded clinical events committee.	Yes, 20 patients no included in intention-to-treat population.	No, RCT, difference in P2Y12 inhibitor loading dose/maintenance dose, time from initiation of anticoagulation to angiography, left main stem disease, right coronary artery disease, left circumflex disease, drug eluting stent, thrombectomy, pre-PCI TIMI flow, CABG during hospitalization, aspirin on discharge, P2Y12 inhibitor on discharge, ACEi/ARB on discharge.
He 201528	Retrospective	Yes	Yes, death from death certificates.	Yes, 328 loss to follow up 1.5%.	Yes, propensity matched analysis. 
Jaffe 200729	Prospective	No 	Yes, clinical data from database confirmed by chart review.	Unclear.	No, cohort, unadjusted results.
Jen 201130	Retrospective	No	Yes, endpoints from outpatient visits.	Unclear.	No, cohort, unadjusted results.
Jin 201031	Retrospective	Yes	Unclear.	Unclear.	No, cohort, unadjusted results.
Johnman 201232	Retrospective 	Yes	Yes, data from Scottish Morbidity Record and the General Registrar for Scotland.	Unclear.	Yes, cohort, adjusted for age, smoking, diabetes, hypertension, non-cardiac valvular disease, renal impairment, left ventricular dysfunction, cardiogenic shock, comorbidity, disease severity, deprivation quintile, indication for PCI, year of procedure and hospital. 
Jolly 20117 & Mehta 201233	RCT	Yes	Yes, outcomes adjudicated by masked central committee.	Yes, 2 loss to follow up.	Yes, RCT, difference in arterial sheath size and number of diagnostic catheter used.
Jurga 20115	RCT	No	Yes, multifrequency Doppler system.	Yes, no loss to follow up.	No, RCT, difference in diabetes mellitus, number of coronary stenosis, fluoroscopy time, number of particulate microemboli, right MCA.
Jurga 201434	Unclear	Yes	Yes, two neurologist evaluated neurological complications.	Yes, 12 cases unverifable.	Yes, cohort, adjusted for age, gender, previous CABG, previous stroke, diabetes, vascular access site.
Kwok 20151	Retrospective	Yes	No, data from BCIS database for in-hospital events.	Yes, 12,103 loss to follow up 2.8%.	No, cohort, unadjusted results. 
Louvard 200435	RCT	Yes	Unclear methods for data collection.	Yes, no loss to follow up reported.	Yes, RCT, difference in diabetes and previous PCI.
Lund 20053	Prospective	No	Yes, Transcranial Doppler and clinical examination  performed by neurologist and MRI.	Yes, no loss to follow up reported.	No, cohort, unadjusted results.
Pristipino 200936	Prospective	Yes	Yes, data prospectively collected with case report form which was transferred to database.  Data was cross checked for consistency by database manager.	Yes no loss to follow up reported.	No, cohort, unadjusted results.
Rapsoso 201537 & Madiera 201338	Prospective	Yes	Yes, data from institutional database and clinical files from each case were reviewed by clinician with preference for neurologist.	Yes, no loss to follow up reported.	Yes, cohort, adjusted for baseline characteristics.
Rodriguez-Leor 201239	Prospective	No	Yes, prospective data collection for the patients' clinical evolution.	Yes, no loss to follow up reported.	No, cohort, unadjusted results.
Romagnoli 201240	RCT	Yes	Yes, end points were adjudicated by blinded central independent clinical events-committee.	Yes, no loss to 1 month follow up.	Yes, RCT, difference in artery puncture-to-balloon time and arterial sheath size.
Romagnoli 201341	Retrospective	Yes	Yes, retrospective from electronic database and checking of hospital charts and direct visit.	Yes, no loss to follow up reported.	No, cohort, unadjusted results.
Sabbah 201342	Retrospective	Yes	Unclear.	Unclear.	No, cohort, unadjusted results.
Sarno 201243	Unclear	Yes	Unclear, data from SCAAR registry.	Unclear.	Yes, cohort, adjusted for differences in clinical, vessel, lesion characteristics, year of procedure and enrolling center.
Sciahbasi 200944	Prospective	Yes	Unclear.	Unclear.	No, cohort, unadjusted results.
Tizon Marcos 200945	Retrospective	Yes	No, retrospective review of charts.	Unclear.	No, cohort, unadjusted results.
Valgimigli 20158	RCT	Yes	Yes, all outcomes were adjudicated by blinded and masked committee.	Yes, 30 patients lost to follow up or refused follow up.	Yes, RCT, difference in unfractionated heparin in catheter lab, left main coronary artery disease, bypass graft.


Table 3: Study outcomes and results
Study ID	Participants; Design	Outcome and follow up	Results
Achenbach 200814	In-patient invasive angiography of age at least 75 years; RCT.	Stroke at up to 96 hours post-procedure.	Stroke: radial group 0/152 vs 1/155.
Benit 199715	Elective PCI for symptomatic IHD; RCT.	In-hospital stroke	In-hospital stroke: radial group 0/50 vs femoral group 1/55.
Bernat 201416	STEMI; RCT.	Peri-PCI stroke, 48h stroke, 30 day stroke.	Peri-PCI stroke: radial group 0/348 vs femoral group 1/359.48h stroke: radial group 1/348 vs femoral group 1/359.30 day stroke: radial group 1/348 vs femoral group 1/359.
Brueck 200917	Patients receiving diagnostic or interventional cardiac catheterization; RCT.	Cerebrovascular accidents	Peri-PCI stroke: radial group 0/512 vs femoral group 2/512.
Chodor 200918	STEMI, RCT.	In-hospital stroke.	In-hospital stroke: radial group 0/50 vs femoral group 1/50.
Chodor 201119	STEMI; RCT.	In-hospital stroke.	In-hospital stroke: radial group 0/49 vs femoral group 1/59.
Cooper 199920	Diagnostic cardiac catheterization; RCT.	Peri-procedural stroke.	Peri-procedural stroke: radial group 0/101 vs femoral group 1/99.
Cruden 200721	Rescue PCI for AMI; Retrospective cohort study.	In-hospital stroke.	In-hospital stroke: radial group 0/44 vs femoral group 3/243.
Dangoisse 201322	PCI; Prospective cohort study.	In-hospital disabling stroke.	In-hospital disabling stroke: radial group 5/1,672 vs femoral group 3/1,928.
De Andrade 201423	STEMI; Prospective cohort study.	6 month stroke.	6 month stroke: radial group 0/178 vs femoral group 3/410. 
Deftereos 201024	STEMI primary PCI; Retrospective cohort study.	In-hospital stroke.	In-hospital stroke: radial group 2/65 vs femoral group 2/33.In-hospital intracranial bleeding; radial group 1/65 vs femoral group 1/33.In-hospital ischemic CVA: radial group 1/65 vs femoral group 1/33.
Eyupkoca 201225	Coronary angiography in elderly; Cohort study.	Stroke unclear follow up.	Stroke: radial group 0/254 vs femoral group 1/186.
Genereux 201126	STEMI; RCT.	1 year stroke.	1 year stroke: radial group 1/200 vs femoral group 30/3,134.
Hamon 20129	Aortic stenosis with coronary catheterization; RCT.	Cerebral infarct at 48 hours after catheterization.	ITT:  Cerebral infarct:  radial: 15/83 vs femoral: 9/77.
Hamon 201527	STEMI; RCT.	30 day stroke.	30 day any stroke: radial group 3/1,012 vs femoral group 13/1,140.30 day ischemic stroke: radial group 3/1,012 vs femoral group 11/1,140.30 day hemorrhagic stroke: radial group 0/1,012 vs femoral group 2/1,140. 
He 201528	Elective PCI; Retrospective cohort study.	In-hospital stroke.	In-hospital stroke propensity matched: radial group 1/1,634 vs femoral group 3/1,634.
Jaffe 200729	Primary PCI in octogenarians; Prospective cohort study.	In-hospital stroke	In-hospital stroke: radial group 1/97 vs femoral group 3/131.
Jen 201130	Primary PCI, Retrospective cohort study.	Peri-procedural intracranial hemorrhage.	Peri-procedural intracranial hemorrhage: radial group 0/85 vs femoral group 1/37 
Jin 201031	PCI; Retrospective cohort study.	In-hospital stroke.	In-hospital stroke: radial group 0/508 vs femoral group 3/508.
Johnman 201232	PCI; Retrospective cohort study.	30 day and 1 year stroke.	Fatal or non-fatal stroke at 30 day: radial vs femoral OR 0.55 (0.18-1.66), at 1 year OR 0.29 (0.1-0.81). 
Jolly 20117 & Mehta 201233	ACS; RCT.	48h stroke,30 day stroke.	48h stroke: radial group 7/3507 vs femoral group 6/3514 OR 1.17 (0.39-3.48)30 day stroke: radial group 20/3,507 vs femoral group 14/3,514, OR 1.43 (0.73-2.80).30 day stroke in STEMI: radial group 5/955 vs femoral group 4/1,003, OR 1.30 (0.35-4.84).30 day stroke in NSTEMI: radial group 15/2,552 vs femoral group 10/2,511, OR 1.48 (0.67-3.30).
Jurga 20115	Stable angina; RCT.	Number of emboli on transcranial Doppler.	Number of particulate microemboli in radial and femoral group were 10.9±6.3 (10 (1-120)) and 6.9±4.7 (6 (1-19)), respectively.
Jurga 201434	Coronary angiogram and PCI; Cohort study.	Periprocedural neurological complication.	Periprocedural neurological complications for radial group 77/77,155 vs 302/151,086. OR 0.94 (0.75-1.17).
Kwok 20151	PCI; Retrospective cohort study.	In-hospital stroke.	In-hospital stroke: radial group 222/177,458, femoral group 288/226,188. 
Louvard 200435	Coronary angiography and PCI; RCT.	Cerebrovascular accident.	Cerebrovascular accident: radial group 0/192 vs 1/185.
Lund 20053	Elective catheterization; Prospective cohort study.	New cerebral DWI lesions.	New cerebral lesions: radial group 5/33 vs 0/9. 
Pristipino 200936	Primary PCI in PREVAIL study; Prospective cohort study.	Peri-procedural stroke	Peri-procedural stroke: radial group 0/509 vs femoral group 1/543
Rapsoso 201537 & Madiera 201338	Diagnostic and interventional procedures; Prospective cohort study.	Stroke or TIA 48 hours after the procedure.	Stroke or TIA: radial group 6/4,195 vs femoral group 20/12,515, adjusted OR 0.86 (0.27-2.7).
Rodriguez-Leor 201239	Emergency PCI and cardiogenic shock; Prospective cohort study.	In-hospital stroke.	In-hospital stroke: radial group 3/80 vs femoral group 2/42.
Romagnoli 201240	Suspected STEACS planned for early revascularizaton; RCT.	30 day stroke	30 day stroke: radial group: 4/500 vs femoral group 3/501Cerebral bleeding: radial group: 1/500 vs femoral group 0/501
Romagnoli 201341	PCI with intraaortic balloon pump; Retrospective cohort study.	30 day stroke.	30 day stroke: radial group 4/112 vs femoral group 4/209.
Sabbah 201342	PCI; Retrospective cohort study.	Stroke.	Stroke: radial group 3/2,797 vs femoral group 5/1,054.
Sarno 201243	Coronary angiogram and PCI; Cohort study.	In-hospital neurological complications.	In-hospital neurological complication: radial group 202/101,060 vs femoral group 397/198,726, OR 1.22 (0.91-1.64).
Sciahbasi 200944	PCI; Prospective cohort study.	Stroke.	Stroke: radial group 1/604 vs femoral group 0/888.TIA: radial group 2/604 vs femoral group 2/888.
Tizon Marcos 200945	Coronary angiogram and PCI; Retrospective cohort study.	Non-hemorrhagic and hemorrhagic stroke.	Stroke: radial group 71/52,191 vs femoral group 66/31,218.Ischemic stroke: radial group 61/52,191 vs femoral group 63/31,218.Hemorrhagic stroke: radial group 10/52,191 vs femoral group 3/31,218. 



































RCT or Cohort studies

Supplementary Figure 2: Risk of stroke with radial and femoral access by study design and procedure type
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